Diagnosis of Primary Ciliary Dyskinesia by a Targeted Next-Generation Sequencing Panel: Molecular and Clinical Findings in Italian Patients

Francesca Boaretto, Deborah Snijders, Cecilia Salvoro, Ambra Spalletta, Maria Luisa Mostacciuolo, Mirella Collura, Salvatore Cazzato, Donata Girosi, Michela Silvestri, Giovanni Arturo Rossi, Angelo Barbato, Giovanni Vazza

Research output: Contribution to journalArticle

Abstract

Primary ciliary dyskinesia (PCD) is a rare genetic disorder that alters mucociliary clearance, with consequent chronic disease of upper and lower airways. Diagnosis of PCD is challenging, and genetic testing is hampered by the high heterogeneity of the disease, because autosomal recessive causative mutations were found in 34 different genes. In this study, we clinically and molecularly characterized a cohort of 51 Italian patients with clinical signs of PCD. A custom next-generation sequencing panel that enables the affordable and simultaneous screening of 24 PCD genes was developed for genetic analysis. After variant filtering and prioritization, the molecular diagnosis of PCD was achieved in 43% of the patients. Overall, 5 homozygous and 27 compound heterozygous mutations, 21 of which were never reported before, were identified in 11 PCD genes. The DNAH5 and DNAH11 genes were the most common cause of PCD in Italy, but some population specificities were identified. In addition, the number of unsolved cases and the identification of only a single mutation in six patients suggest further genetic heterogeneity and invoke the need of novel strategies to detect unconventional pathogenic DNA variants. Finally, despite the availability of mutation databases and in silico prediction tools helping the interpretation of variants in next-generation sequencing screenings, a comprehensive segregation analysis is required to establish the in trans inheritance and support the pathogenic role of mutations.

Original languageEnglish
Pages (from-to)912-922
Number of pages11
JournalJournal of Molecular Diagnostics
Volume18
Issue number6
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Kartagener Syndrome
Mutation
Genes
Mucociliary Clearance
Inborn Genetic Diseases
Genetic Heterogeneity
Genetic Testing
Computer Simulation
Italy
Chronic Disease
Databases
DNA
Population

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine

Cite this

Diagnosis of Primary Ciliary Dyskinesia by a Targeted Next-Generation Sequencing Panel : Molecular and Clinical Findings in Italian Patients. / Boaretto, Francesca; Snijders, Deborah; Salvoro, Cecilia; Spalletta, Ambra; Mostacciuolo, Maria Luisa; Collura, Mirella; Cazzato, Salvatore; Girosi, Donata; Silvestri, Michela; Rossi, Giovanni Arturo; Barbato, Angelo; Vazza, Giovanni.

In: Journal of Molecular Diagnostics, Vol. 18, No. 6, 01.11.2016, p. 912-922.

Research output: Contribution to journalArticle

Boaretto, F, Snijders, D, Salvoro, C, Spalletta, A, Mostacciuolo, ML, Collura, M, Cazzato, S, Girosi, D, Silvestri, M, Rossi, GA, Barbato, A & Vazza, G 2016, 'Diagnosis of Primary Ciliary Dyskinesia by a Targeted Next-Generation Sequencing Panel: Molecular and Clinical Findings in Italian Patients', Journal of Molecular Diagnostics, vol. 18, no. 6, pp. 912-922. https://doi.org/10.1016/j.jmoldx.2016.07.002
Boaretto, Francesca ; Snijders, Deborah ; Salvoro, Cecilia ; Spalletta, Ambra ; Mostacciuolo, Maria Luisa ; Collura, Mirella ; Cazzato, Salvatore ; Girosi, Donata ; Silvestri, Michela ; Rossi, Giovanni Arturo ; Barbato, Angelo ; Vazza, Giovanni. / Diagnosis of Primary Ciliary Dyskinesia by a Targeted Next-Generation Sequencing Panel : Molecular and Clinical Findings in Italian Patients. In: Journal of Molecular Diagnostics. 2016 ; Vol. 18, No. 6. pp. 912-922.
@article{0bbfe73dec504be0bbd937e13776eb19,
title = "Diagnosis of Primary Ciliary Dyskinesia by a Targeted Next-Generation Sequencing Panel: Molecular and Clinical Findings in Italian Patients",
abstract = "Primary ciliary dyskinesia (PCD) is a rare genetic disorder that alters mucociliary clearance, with consequent chronic disease of upper and lower airways. Diagnosis of PCD is challenging, and genetic testing is hampered by the high heterogeneity of the disease, because autosomal recessive causative mutations were found in 34 different genes. In this study, we clinically and molecularly characterized a cohort of 51 Italian patients with clinical signs of PCD. A custom next-generation sequencing panel that enables the affordable and simultaneous screening of 24 PCD genes was developed for genetic analysis. After variant filtering and prioritization, the molecular diagnosis of PCD was achieved in 43{\%} of the patients. Overall, 5 homozygous and 27 compound heterozygous mutations, 21 of which were never reported before, were identified in 11 PCD genes. The DNAH5 and DNAH11 genes were the most common cause of PCD in Italy, but some population specificities were identified. In addition, the number of unsolved cases and the identification of only a single mutation in six patients suggest further genetic heterogeneity and invoke the need of novel strategies to detect unconventional pathogenic DNA variants. Finally, despite the availability of mutation databases and in silico prediction tools helping the interpretation of variants in next-generation sequencing screenings, a comprehensive segregation analysis is required to establish the in trans inheritance and support the pathogenic role of mutations.",
author = "Francesca Boaretto and Deborah Snijders and Cecilia Salvoro and Ambra Spalletta and Mostacciuolo, {Maria Luisa} and Mirella Collura and Salvatore Cazzato and Donata Girosi and Michela Silvestri and Rossi, {Giovanni Arturo} and Angelo Barbato and Giovanni Vazza",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.jmoldx.2016.07.002",
language = "English",
volume = "18",
pages = "912--922",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "6",

}

TY - JOUR

T1 - Diagnosis of Primary Ciliary Dyskinesia by a Targeted Next-Generation Sequencing Panel

T2 - Molecular and Clinical Findings in Italian Patients

AU - Boaretto, Francesca

AU - Snijders, Deborah

AU - Salvoro, Cecilia

AU - Spalletta, Ambra

AU - Mostacciuolo, Maria Luisa

AU - Collura, Mirella

AU - Cazzato, Salvatore

AU - Girosi, Donata

AU - Silvestri, Michela

AU - Rossi, Giovanni Arturo

AU - Barbato, Angelo

AU - Vazza, Giovanni

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Primary ciliary dyskinesia (PCD) is a rare genetic disorder that alters mucociliary clearance, with consequent chronic disease of upper and lower airways. Diagnosis of PCD is challenging, and genetic testing is hampered by the high heterogeneity of the disease, because autosomal recessive causative mutations were found in 34 different genes. In this study, we clinically and molecularly characterized a cohort of 51 Italian patients with clinical signs of PCD. A custom next-generation sequencing panel that enables the affordable and simultaneous screening of 24 PCD genes was developed for genetic analysis. After variant filtering and prioritization, the molecular diagnosis of PCD was achieved in 43% of the patients. Overall, 5 homozygous and 27 compound heterozygous mutations, 21 of which were never reported before, were identified in 11 PCD genes. The DNAH5 and DNAH11 genes were the most common cause of PCD in Italy, but some population specificities were identified. In addition, the number of unsolved cases and the identification of only a single mutation in six patients suggest further genetic heterogeneity and invoke the need of novel strategies to detect unconventional pathogenic DNA variants. Finally, despite the availability of mutation databases and in silico prediction tools helping the interpretation of variants in next-generation sequencing screenings, a comprehensive segregation analysis is required to establish the in trans inheritance and support the pathogenic role of mutations.

AB - Primary ciliary dyskinesia (PCD) is a rare genetic disorder that alters mucociliary clearance, with consequent chronic disease of upper and lower airways. Diagnosis of PCD is challenging, and genetic testing is hampered by the high heterogeneity of the disease, because autosomal recessive causative mutations were found in 34 different genes. In this study, we clinically and molecularly characterized a cohort of 51 Italian patients with clinical signs of PCD. A custom next-generation sequencing panel that enables the affordable and simultaneous screening of 24 PCD genes was developed for genetic analysis. After variant filtering and prioritization, the molecular diagnosis of PCD was achieved in 43% of the patients. Overall, 5 homozygous and 27 compound heterozygous mutations, 21 of which were never reported before, were identified in 11 PCD genes. The DNAH5 and DNAH11 genes were the most common cause of PCD in Italy, but some population specificities were identified. In addition, the number of unsolved cases and the identification of only a single mutation in six patients suggest further genetic heterogeneity and invoke the need of novel strategies to detect unconventional pathogenic DNA variants. Finally, despite the availability of mutation databases and in silico prediction tools helping the interpretation of variants in next-generation sequencing screenings, a comprehensive segregation analysis is required to establish the in trans inheritance and support the pathogenic role of mutations.

UR - http://www.scopus.com/inward/record.url?scp=84992491575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992491575&partnerID=8YFLogxK

U2 - 10.1016/j.jmoldx.2016.07.002

DO - 10.1016/j.jmoldx.2016.07.002

M3 - Article

AN - SCOPUS:84992491575

VL - 18

SP - 912

EP - 922

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 6

ER -